Centaurus Financial »

Halozyme Therapeutics shares owned by Centaurus Financial

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Centaurus Financial from 13F filings

Historical chart of Centaurus Financial investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Centaurus Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Centaurus Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 22k 73.34
2025-06-30 $1.2M 22k 52.04
2025-03-31 $1.4M 22k 63.81
2024-09-30 $127k 2.2k 57.23
2018-06-30 $10k 610 16.39